SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 91 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $1,299,000 | +60.6% | 72,346 | +5.5% | 0.00% | +100.0% |
Q3 2017 | $809,000 | +12.5% | 68,578 | +0.1% | 0.00% | 0.0% |
Q2 2017 | $719,000 | -1.8% | 68,499 | +2.9% | 0.00% | 0.0% |
Q1 2017 | $732,000 | -88.9% | 66,546 | -86.3% | 0.00% | -90.0% |
Q4 2016 | $6,572,000 | +6.2% | 485,018 | -3.5% | 0.01% | 0.0% |
Q3 2016 | $6,189,000 | +18.2% | 502,729 | +5.3% | 0.01% | +11.1% |
Q2 2016 | $5,235,000 | +13.1% | 477,229 | +12.7% | 0.01% | +12.5% |
Q1 2016 | $4,628,000 | -12.4% | 423,391 | +38.5% | 0.01% | -20.0% |
Q4 2015 | $5,285,000 | -6.6% | 305,691 | +7.4% | 0.01% | -9.1% |
Q3 2015 | $5,657,000 | +762.3% | 284,723 | +613.5% | 0.01% | +1000.0% |
Q2 2015 | $656,000 | +65.2% | 39,905 | +56.4% | 0.00% | 0.0% |
Q1 2015 | $397,000 | +25.2% | 25,516 | +14.8% | 0.00% | 0.0% |
Q4 2014 | $317,000 | +120.1% | 22,217 | 0.0% | 0.00% | – |
Q3 2014 | $144,000 | -5.9% | 22,217 | 0.0% | 0.00% | – |
Q2 2014 | $153,000 | +1.3% | 22,217 | +5.1% | 0.00% | – |
Q1 2014 | $151,000 | -24.1% | 21,132 | 0.0% | 0.00% | – |
Q4 2013 | $199,000 | +50.8% | 21,132 | 0.0% | 0.00% | – |
Q3 2013 | $132,000 | +14.8% | 21,132 | +20.9% | 0.00% | – |
Q2 2013 | $115,000 | – | 17,482 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADVANTAGE INVESTMENT MANAGEMENT, LLC | 311 | $6,000 | 0.00% |
NOMURA HOLDINGS INC | 33,500 | $599,000 | 0.00% |
IFP Advisors, Inc | 384 | $7,000 | 0.00% |
GLENMEDE TRUST CO NA | 461 | $8,000 | 0.00% |